Insulet
$193.51
59
-$1.52-0.78% Friday 20:00
统计数据
当日最高
196.94
当日最低
191.94
52周最高
223.56
52周最低
125.82
成交量
510,272
平均成交量
791,601
市值
13.57B
市盈率
36.93
股息收益率
-
股息
-
即将到来
收益
31Oct已确认
预期每股收益
0.75838
实际每股收益
N/A
人们还关注
此列表基于关注PODD的Stock Events用户的观察列表。这不是投资建议。
竞争者
这个列表是基于最近市场事件的分析。这不是投资建议。
Tandem Diabetes Care
TNDM
市值2.45B
Medtronic
MDT
市值108.51B
Dexcom
DXCM
市值29.91B
Abbott Laboratories
ABT
市值193.13B
Insulet
PODD
市值12.76B
Senseonics
SENS
市值221.08M
Novo Nordisk
NVO
市值457.29B
Sanofi
SNY
市值137.19B
Mannkind
MNKD
市值1.39B
分析师评级
229$平均价格目标
最高估值为 $260。
来自过去6个月内的 11 个评级。这不是投资建议。
买入
73%
持有
27%
卖出
0%
关于
Health Technology
Medical Specialties
Manufacturing
Surgical and Medical Instrument Manufacturing
Insulet Corporation develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes. It offers Omnipod System, a self-adhesive disposable tubeless Omnipod device that is worn on the body for up to three days at a time, as well as its wireless companion, the handheld personal diabetes manager. The company sells its products primarily through independent distributors and pharmacy channels, as well as directly in the United States, Canada, Europe, the Middle East, and Australia. Insulet Corporation was incorporated in 2000 and is headquartered in Acton, Massachusetts.
Show more...
首席执行官
Shacey Petrovic
员工
3000
国家
US
ISIN
US45784P1012
WKN
000A0MQX8